What is Tute Genomics?
Tute Genomics operates a sophisticated cloud platform engineered to simplify the complex interpretation of genomic data. By providing researchers and healthcare professionals with a streamlined interface for genetic analysis, the company addresses the growing demand for accessible, high-throughput bioinformatics tools. Its market position is defined by its ability to translate raw genetic information into actionable clinical insights, thereby facilitating more efficient research workflows and personalized medical interventions. The firm remains a pivotal entity for stakeholders focused on the digital transformation of life sciences.
How much funding has Tute Genomics raised?
Tute Genomics has raised a total of $6.3M across 3 funding rounds:
Angel/Seed
$1.5M
Series A
$3.9M
Private Equity
$868K
Angel/Seed (2013): $1.5M with participation from Peak Ventures, Park City Angels, Salt Lake Life Science Angels, and Wilmington PharmaTech Company, LLC
Series A (2015): $3.9M led by Healthbox, Tencent, and Intermountain Health
Private Equity (2015): $868K supported by Peak Ventures
Key Investors in Tute Genomics
Peak Ventures
Peak Ventures is a venture capital and private equity firm based in Lehi, Utah, focused on supporting high-growth early-stage companies.
Park City Angels
Park City Angels is a prominent network of accredited investors in Utah dedicated to funding disruptive early-stage ventures with significant growth potential.
Tencent
Tencent is a global technology conglomerate that invests in digital innovation, cloud computing, and enterprise solutions across international markets.
What's next for Tute Genomics?
With the support of its latest strategic financing, Tute Genomics is well-positioned to accelerate its product development roadmap and expand its footprint in the global healthcare market. The company is expected to leverage this capital to enhance its algorithmic capabilities, ensuring that its cloud platform remains at the forefront of genomic data processing. As the industry shifts toward data-driven diagnostics, Tute Genomics is poised to capitalize on the increasing integration of genetic insights into standard clinical practice, potentially driving further enterprise-level adoption and long-term value creation.
See full Tute Genomics company page
